BIRC2 and breast cancer: Breast cancer patients in TNM stages I, II, III, and IV showed 9.54, 11.80, 15.19, and 16.83 mean fold increased cIAP-1 mRNA expression, and the difference among them was found to be statistically significant, respectively (p=0.004).